Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

447 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.
Kremer JM, Genovese MC, Cannon GW, Caldwell JR, Cush JJ, Furst DE, Luggen ME, Keystone E, Weisman MH, Bensen WM, Kaine JL, Ruderman EM, Coleman P, Curtis DL, Kopp EJ, Kantor SM, Waltuck J, Lindsley HB, Markenson JA, Strand V, Crawford B, Fernando I, Simpson K, Bathon JM. Kremer JM, et al. Among authors: keystone e. Ann Intern Med. 2002 Nov 5;137(9):726-33. doi: 10.7326/0003-4819-137-9-200211050-00007. Ann Intern Med. 2002. PMID: 12416946 Clinical Trial.
Biologic agents in autoimmune diseases.
Keystone EC, Strand V. Keystone EC, et al. J Rheumatol. 1996 Apr;23(4):743-6. J Rheumatol. 1996. PMID: 8730137 No abstract available.
Biologic agents for the treatment of rheumatoid arthritis.
Strand V, Keystone E, Breedveld F. Strand V, et al. Among authors: keystone e. Rheum Dis Clin North Am. 1996 Feb;22(1):117-32. doi: 10.1016/s0889-857x(05)70265-9. Rheum Dis Clin North Am. 1996. PMID: 8907068 Free article. Review.
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.
Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann RM, Bulpitt KJ, Weaver AL, Keystone EC, Furst DE, Mease PJ, Ruderman EM, Horwitz DA, Arkfeld DG, Garrison L, Burge DJ, Blosch CM, Lange ML, McDonnell ND, Weinblatt ME. Moreland LW, et al. Among authors: keystone ec. Ann Intern Med. 1999 Mar 16;130(6):478-86. doi: 10.7326/0003-4819-130-6-199903160-00004. Ann Intern Med. 1999. PMID: 10075615 Clinical Trial.
Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000).
Furst DE, Breedveld FC, Burmester GR, Crofford JJ, Emery P, Feldmann M, Kalden JR, Kavanaugh AF, Keystone EC, Klareskog LG, Lipsky PE, Maini RN, Russell AS, Scott DL, Smolen JS, Van de Putte LB, Visher TL, Weisman MH. Furst DE, et al. Among authors: keystone ec. Ann Rheum Dis. 2000 Nov;59 Suppl 1(Suppl 1):i1-2. doi: 10.1136/ard.59.suppl_1.i1. Ann Rheum Dis. 2000. PMID: 11053077 Free PMC article. Review. No abstract available.
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.
Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Genovese MC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Finck BK. Bathon JM, et al. Among authors: keystone ec. N Engl J Med. 2000 Nov 30;343(22):1586-93. doi: 10.1056/NEJM200011303432201. N Engl J Med. 2000. PMID: 11096165 Free article. Clinical Trial.
Biologic agents in the treatment of rheumatoid arthritis.
Haraoui B, Strand V, Keystone E. Haraoui B, et al. Among authors: keystone e. Curr Pharm Biotechnol. 2000 Nov;1(3):217-33. doi: 10.2174/1389201003378915. Curr Pharm Biotechnol. 2000. PMID: 11469381 Review.
447 results